Eric Arthur

Economics

About

Eric Arthur holds a PhD in Economics from the University of Benin, Nigeria. He had both his first and second degrees in Economics from the University of Ghana. His special interests are in Health Economics, Econometrics, and Public Finance. He is currently a Senior Lecturer at the Department of Economics in the Kwame Nkrumah University of Science and Technology, where he teaches Health Economics and Econometrics at both the graduate and undergraduate levels. He also teaches courses in Domestic finance for development at the graduate level. Eric’s research focuses on reproductive health and health care financing. He has also done some work on the demographic dividend using the National Transfer Account Approach for the United Nations Population Fund and the National Development Planning Commission.

Research Summary

(inferred from publications by AI)

Botulum Neurotoxin in Health: Understanding Neurotoxicity and Microbial Impact Gut Microbiota's Role in Health Outcomes: Their research highlights the importance of microbial processes in maintaining food safety. Essential Oils and Antimicrobial Activity: The role of essential oils like Phaffia rhodozyma contributes to broader microbial biosecurity studies. Phaffia Rhodooza in Plant Biology: Their focus on Phaffia rhodozyma explores its impact on carotenoid production, tying into plant biology. Metabolic Engineering and Bioproduction: Using yeasts like Phaffia rhodozyma in food processing reflects broader metabolic engineering applications. Cancer Screening and Detection: Their studies on adverse events after colonoscopy underscore the importance of microbiological knowledge in public health.

Research Themes

All (100 Papers)

Health Sciences (71 Papers)

Life Sciences (28 Papers)

Physical Sciences (1 Papers)

All Papers

SV2 Is the Protein Receptor for Botulinum Neurotoxin A(2006)

Properties and use of botulinum toxin and other microbial neurotoxins in medicine(1992)

Genetic Diversity among Botulinum Neurotoxin-Producing Clostridial Strains(2006)

Evaluation of the Therapeutic Usefulness of Botulinum Neurotoxin B, C1, E, and F Compared with the Long Lasting Type A(2003)

Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells(2003)

Sequence Variation within Botulinum Neurotoxin Serotypes Impacts Antibody Binding and Neutralization(2005)

Glycosylated SV2A and SV2B Mediate the Entry of Botulinum Neurotoxin E into Neurons(2008)

Structural basis of cell surface receptor recognition by botulinum neurotoxin B(2006)

Properties and use of botulinum toxin and other microbial neurotoxins in medicine.(1992)

Clostridial Toxins as Therapeutic Agents: Benefits of Nature's Most Toxic Proteins(1999)

SV2 Mediates Entry of Tetanus Neurotoxin into Central Neurons(2010)

A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure With Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A Antitoxin(2015)

Botulinum Neurotoxin D Uses Synaptic Vesicle Protein SV2 and Gangliosides as Receptors(2011)

A Structural Perspective of the Sequence Variability Within Botulinum Neurotoxin Subtypes A1-A4(2006)

Chapter 11 Botulism(2008)

An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists(2007)

Characterization of Botulinum Neurotoxin A Subtypes 1 Through 5 by Investigation of Activities in Mice, in Neuronal Cell Cultures, and In Vitro(2013)

Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons(2007)

Bimodal modulation of the botulinum neurotoxin protein-conducting channel(2009)

Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1(2010)

Novel Application of Human Neurons Derived from Induced Pluripotent Stem Cells for Highly Sensitive Botulinum Neurotoxin Detection(2012)

Persistence of Botulinum Neurotoxin A Subtypes 1-5 in Primary Rat Spinal Cord Cells(2014)

Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain(2016)

Genetic Homogeneity of Clostridium botulinum Type A1 Strains with Unique Toxin Gene Clusters(2008)

Botulinum toxin therapy: past, present and future developments(2022)

Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond.(1994)

Botulinum toxin therapy, immunologic resistance, and problems with available materials(1996)

Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective(2001)

Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells(2004)

Structural Determinants of the Specificity for Synaptic Vesicle-associated Membrane Protein/Synaptobrevin of Tetanus and Botulinum Type B and G Neurotoxins(1996)

Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects(2001)

Subunit Vaccine against the Seven Serotypes of Botulism(2007)

Pure Botulinum Neurotoxin Is Absorbed from the Stomach and Small Intestine and Produces Peripheral Neuromuscular Blockade(1999)

A Large Outbreak of Botulism: The Hazardous Baked Potato(1998)

Microfluidic tectonics platform: A colorimetric, disposable botulinum toxin enzyme‐linked immunosorbent assay system(2004)

Cytotoxicity of botulinum neurotoxins reveals a direct role of syntaxin 1 and SNAP-25 in neuron survival(2013)

Genetic Characterization of Clostridium botulinum Type A Containing Silent Type B Neurotoxin Gene Sequences(1996)

Botulinum neurotoxin D-C uses synaptotagmin I/II as receptors and human synaptotagmin II is not an effective receptor for type B, D-C, and G toxins(2012)

Detection of Botulinal Neurotoxins A, B, E, and F by Amplified Enzyme-Linked Immunosorbent Assay: Collaborative Study(2003)

Neurotoxin Gene Clusters in Clostridium botulinum Type A Strains: Sequence Comparison and Evolutionary Implications(2003)

Purification of Clostridium botulinum Type A Neurotoxin(2003)

A neuronal cell‐based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies(2007)

In vivo onset and duration of action varies for botulinum neurotoxin A subtypes 1-5(2015)

Botulinum Toxin for Aberrant Facial Nerve Regeneration: Double-Blind, Placebo-Controlled Trial Using Subjective Endpoints(2005)

Interneuronal Transfer and Distal Action of Tetanus Toxin and Botulinum Neurotoxins A and D in Central Neurons(2016)

Characterization of Clostridium botulinum Strains Associated with an Infant Botulism Case in the United Kingdom(2005)

Analysis of Neurotoxin Cluster Genes in Clostridium botulinum Strains Producing Botulinum Neurotoxin Serotype A Subtypes(2008)

Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin(2010)

The genes for the Clostridium botulinum type G toxin complex are on a plasmid(1995)

Phylogenetic analysis of Clostridium botulinum type A by multi-locus sequence typing(2008)

Genome analysis of Clostridium botulinum type A by pulsed-field gel electrophoresis(1995)

Catalytic Properties of Botulinum Neurotoxin Subtypes A3 and A4(2009)

Plasmid encoded neurotoxin genes in Clostridium botulinum serotype A subtypes(2007)

Receptor Binding Enables Botulinum Neurotoxin B to Sense Low pH for Translocation Channel Assembly(2011)

Botulinum Neurotoxin Detection Methods for Public Health Response and Surveillance(2018)

Gastrointestinal Microflora Studies in Late‐Onset Autism(2002)

The Group Health Medical Home At Year Two: Cost Savings, Higher Patient Satisfaction, And Less Burnout For Providers(2010)

Astaxanthin from Microbial Sources(1991)

Astaxanthin Formation by the Yeast Phaffia rhodozyma(1979)

Isolation of Phaffia rhodozyma Mutants with Increased Astaxanthin Content(1989)

Singlet Oxygen and Peroxyl Radicals Regulate Carotenoid Biosynthesis in Phaffia rhodozyma(1995)

Phaffia rhodozyma : colorful odyssey(2003)

Carotenoids protectPhaffia rhodozyma against singlet oxygen damage(1995)

Monocyclic carotenoid biosynthetic pathway in the yeast Phaffia rhodozyma (Xanthophyllomyces dendrorhous)(1999)

Acid adaptation induces cross-protection against environmental stresses in Salmonella typhimurium(1993)

Acid adaptation promotes survival of Salmonella spp. in cheese(1992)

Acid adaptation sensitizes Salmonella typhimurium to hypochlorous acid(1997)

Acid adaptation of Escherichia coli O157:H7 increases survival in acidic foods(1995)

Development of an improved chemically defined minimal medium for Listeria monocytogenes(1991)

Inhibition of Listeria monocytogenes by fatty acids and monoglycerides(1992)

Microbiological Safety of Cheese Made from Heat-Treated Milk, Part II. Microbiology(1990)

Antibacterial activity of hen egg white lysozyme against Listeria monocytogenes Scott A in foods(1989)

Survival of Listeria monocytogenes in Commercial Cheese Brines(1999)

Antimicrobial activity of hop extracts against Listeria monocytogenes in media and in food(1996)

Reactive oxygen species mediate pollen tube rupture to release sperm for fertilization in Arabidopsis(2014)

Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity(2018)

Sensitization ofStaphylococcus aureusandEscherichia colito Antibiotics by the Sesquiterpenoids Nerolidol, Farnesol, Bisabolol, and Apritone(2003)

Naturally Occurring Antimicrobials in Food(1998)

Antimicrobial activity of lysozyme against bacteria involved in food spoilage and food-borne disease(1987)

Evaluating the Safety of Microbial Enzyme Preparations Used in Food Processing: Update for a New Century(2001)

Microbial carotenoids(1995)

Biotechnology of non-Saccharomyces yeasts—the ascomycetes(2012)

Klebsiella pneumoniae 1,3-propanediol:NAD+ oxidoreductase(1987)

The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease(2011)

Prevalence and treatment of opioid use disorders among primary care patients in six health systems(2019)

Chemically Defined Minimal Medium for Growth of the Anaerobic Cellulolytic Thermophile Clostridium thermocellum(1981)

Phaffia rhodozyma as an astaxanthin source in salmonid diets(1980)

Spores and Their Significance(2019)

Mixed cultures in biotechnology(1991)

Antioxidant role of carotenoids in Phaffia rhodozyma(1993)

Adverse events after screening and follow-up colonoscopy(2011)

Secular Trends in Colon and Rectal Cancer Relative Survival(2013)

Bleeding Stomal Varices: Case Series and Systematic Review of the Literature(2008)

Ethanol increases carotenoid production in Phaffia rhodozyma(1997)

brp and blh Are Required for Synthesis of the Retinal Cofactor of Bacteriorhodopsin in Halobacterium salinarum(2001)

Yeast Biotechnology(2011)

A MEMS Photosynthetic Electrochemical Cell Powered by Subcellular Plant Photosystems(2006)

Biotechnology of non-Saccharomyces yeasts—the basidiomycetes(2013)

T<scp>HE</scp> C<scp>HLOROPLAST</scp> ATP S<scp>YNTHASE</scp>: A Rotary Enzyme?(2000)

Antagonistic effect of fat on the antibotulinal activity of food preservatives and fatty acids(2004)

Collaboration Network

No collaborations found in the dataset.

About This Profile

This profile is generated from publicly available publication metadata and is intended for research discovery purposes. Themes, summaries, and trajectories are inferred computationally and may not capture the full scope of the lecturer's work. For authoritative information, please refer to the official KNUST profile.